Evaluation of ischemic stroke and recurrent ischemic attack

M. L. Wynn, Bruce M Coull

Research output: Contribution to journalArticle

Abstract

Stroke is the leading cause of adult disability in the United States, with an annual cost of $30 billion. Defining stroke etiology is essential for initial treatment and prevention of recurrent stroke. In this article, we discuss the laboratory evaluation of patients with cerebral ischemia. In most patients older than 50 years with clear risk factors, the analysis is straightforward and inexpensive. In younger patients or those without standard risk factors, however, further laboratory investigation often is necessary. We discuss specific laboratory tests investigating common etiologies, such as atherothrombosis, and uncommon causes including prothrombotic states, metabolic abnormalities, and hyperviscosity syndromes. Optimally, a focused investigation defines etiology and evaluates risk factors, thus reducing risk of recurrent stroke and improving long-term outcome. This is the final article in a three-part continuing education series on neurology. Other articles focused on multiple sclerosis and neuropathy syndromes. The exam follows this article.

Original languageEnglish (US)
Pages (from-to)519-525
Number of pages7
JournalLaboratory Medicine
Volume26
Issue number8
StatePublished - 1995
Externally publishedYes

Fingerprint

Stroke
Continuing Education
Neurology
Brain Ischemia
Statistical Factor Analysis
Multiple Sclerosis
Education
Costs and Cost Analysis
Costs
Therapeutics

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Pathology and Forensic Medicine

Cite this

Evaluation of ischemic stroke and recurrent ischemic attack. / Wynn, M. L.; Coull, Bruce M.

In: Laboratory Medicine, Vol. 26, No. 8, 1995, p. 519-525.

Research output: Contribution to journalArticle

@article{b698771436ae4dc887fd4c4641463998,
title = "Evaluation of ischemic stroke and recurrent ischemic attack",
abstract = "Stroke is the leading cause of adult disability in the United States, with an annual cost of $30 billion. Defining stroke etiology is essential for initial treatment and prevention of recurrent stroke. In this article, we discuss the laboratory evaluation of patients with cerebral ischemia. In most patients older than 50 years with clear risk factors, the analysis is straightforward and inexpensive. In younger patients or those without standard risk factors, however, further laboratory investigation often is necessary. We discuss specific laboratory tests investigating common etiologies, such as atherothrombosis, and uncommon causes including prothrombotic states, metabolic abnormalities, and hyperviscosity syndromes. Optimally, a focused investigation defines etiology and evaluates risk factors, thus reducing risk of recurrent stroke and improving long-term outcome. This is the final article in a three-part continuing education series on neurology. Other articles focused on multiple sclerosis and neuropathy syndromes. The exam follows this article.",
author = "Wynn, {M. L.} and Coull, {Bruce M}",
year = "1995",
language = "English (US)",
volume = "26",
pages = "519--525",
journal = "Laboratory Medicine",
issn = "0007-5027",
publisher = "American Society of Clinical Pathologists",
number = "8",

}

TY - JOUR

T1 - Evaluation of ischemic stroke and recurrent ischemic attack

AU - Wynn, M. L.

AU - Coull, Bruce M

PY - 1995

Y1 - 1995

N2 - Stroke is the leading cause of adult disability in the United States, with an annual cost of $30 billion. Defining stroke etiology is essential for initial treatment and prevention of recurrent stroke. In this article, we discuss the laboratory evaluation of patients with cerebral ischemia. In most patients older than 50 years with clear risk factors, the analysis is straightforward and inexpensive. In younger patients or those without standard risk factors, however, further laboratory investigation often is necessary. We discuss specific laboratory tests investigating common etiologies, such as atherothrombosis, and uncommon causes including prothrombotic states, metabolic abnormalities, and hyperviscosity syndromes. Optimally, a focused investigation defines etiology and evaluates risk factors, thus reducing risk of recurrent stroke and improving long-term outcome. This is the final article in a three-part continuing education series on neurology. Other articles focused on multiple sclerosis and neuropathy syndromes. The exam follows this article.

AB - Stroke is the leading cause of adult disability in the United States, with an annual cost of $30 billion. Defining stroke etiology is essential for initial treatment and prevention of recurrent stroke. In this article, we discuss the laboratory evaluation of patients with cerebral ischemia. In most patients older than 50 years with clear risk factors, the analysis is straightforward and inexpensive. In younger patients or those without standard risk factors, however, further laboratory investigation often is necessary. We discuss specific laboratory tests investigating common etiologies, such as atherothrombosis, and uncommon causes including prothrombotic states, metabolic abnormalities, and hyperviscosity syndromes. Optimally, a focused investigation defines etiology and evaluates risk factors, thus reducing risk of recurrent stroke and improving long-term outcome. This is the final article in a three-part continuing education series on neurology. Other articles focused on multiple sclerosis and neuropathy syndromes. The exam follows this article.

UR - http://www.scopus.com/inward/record.url?scp=0029145188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029145188&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 519

EP - 525

JO - Laboratory Medicine

JF - Laboratory Medicine

SN - 0007-5027

IS - 8

ER -